<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413190</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00031738</org_study_id>
    <nct_id>NCT02413190</nct_id>
  </id_info>
  <brief_title>Bone Health in Facioscapulohumeral Muscular Dystrophy</brief_title>
  <acronym>FSHD</acronym>
  <official_title>Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Concord Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FSHD Global Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional single visit study to determine bone health in individuals with
      FSHD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone health will be assessed using 1) a DEXA scan to measure bone mineral density and lean
      body mass, and 2) blood tests of biomarkers of bone resorption and formation. These
      procedures will be correlated to measures of muscle strength testing and timed function tests
      to determine fracture risk in FSHD individuals considering age, gender, muscle strength and
      FSHD allele size.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density in FSHD</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if bone mineral density is reduced in individuals with FSHD compared to normative data of individuals of the same age and gender without FSHD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fracture frequency</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if individuals with FSHD have more fractures compared to normative data of individuals of the same age and gender without FSHD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with muscle strength and timed function testing</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if bone mineral density and lean body mass or fracture history correlate with leg muscle strength or timed function tests in FSHD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with Allele size</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if bone mineral density and lean body mass or fracture history correlate with FSHD allele size.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with bone health markers</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if serum markers of bone health correlate with bone mineral density in FSHD.</description>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Facioscapulohumeral Muscular Dystrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The population consists of individuals with Facioscapulohumeral Muscular Dystrophy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Genetic diagnosis of FSHD including chromosome 4 deletion and haplotype

          -  Age &gt; 18 years

          -  Ability to provide written informed consent for participation in the study

          -  Ability to participate in the DEXA scan

        Exclusion Criteria:

          -  Unwillingness or inability to comply with the requirements of this protocol (in the
             opinion of the PI) including, but not limited to, the presence of any condition
             (physical, mental or social) that precludes the participant from comfortably and
             safely obtaining a DEXA scan, phlebotomy, or neurological examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kennedy Krieger Institute, Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Concord Hospital Neurology Department, Hospital Road, Concord NSW 2139</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2015</study_first_posted>
  <last_update_submitted>May 18, 2016</last_update_submitted>
  <last_update_submitted_qc>May 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Facioscapulohumeral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>August 23, 2017</submitted>
    <returned>March 19, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

